GridAI Technologies Corp. (GRDX)
Last updated: 2026-11-06 18:52:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
GridAI Technologies Corp. (GRDX) operates in the ELECTRIC & OTHER SERVICES COMBINED sector and is listed on NASDAQ. The stock is currently priced at $4.84, with a market capitalization of $48.27M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.87 to $6.93. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$48.27M | |
$4.61 | |
$6.93 | |
$1.87 | |
$4.67 | |
40.67K | |
118.74K | |
-- | |
$6.93 | |
$1.87 | |
-- | |
-- |
GridAI Technologies Corp. (GRDX) Stock Price Today
GridAI Technologies Corp. (GRDX) is currently trading at $4.84 as of 2026-11-06 18:50:00, up 3.62% ($0.17) from the previous close of $4.67
During today's regular trading session, GRDX has traded between $1.87 and $6.93, with a trading volume of 40.67K shares. The current price is near the middle of today's range.
GridAI Technologies Corp. (GRDX) 7-Day Stock Price Change
Over the past seven days, GridAI Technologies Corp. (GRDX) moved from $5.76 to $4.84, representing a decline of 15.99% ($0.92).
The stock traded between $4.50 and $6.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 123.68 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
GRDX 52-Week Price Position
Position in Range: 58.7%
GRDX is currently trading at $4.84, placing it 58.7% of the way from its 52-week low of $1.87 to its 52-week high of $6.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is GridAI Technologies Corp. (GRDX)?
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
GridAI Technologies Corp. Information
| Industry | ELECTRIC & OTHER SERVICES COMBINED |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy GridAI Technologies Corp. (GRDX) Stock on MEXC
Eligible investors can buy real shares of GridAI Technologies Corp. (GRDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is GridAI Technologies Corp. (GRDX) stock price today?
2.Is GRDX stock going up or down today?
3.What is GRDX pre-market price?
4.What is GRDX after-hours price?
5.Is GRDX stock trading now?
6.Where does GRDX sit relative to its 52-week high and low?
7.What sector is GridAI Technologies Corp. in?
8.What is GridAI Technologies Corp.'s market capitalization and where is it listed?
9.How is GRDX valued in terms of P/E ratio and EPS?
10.Does GridAI Technologies Corp. pay a dividend?
Explore More US Stocks
Search Stocks
GRDX Stock Calculator
Estimate the value between GRDX shares and USD.
GRDX Shares to USD
1.00 GRDX shares = 4.839 USD
Calculations are estimates based on the latest available price and are for reference only.



